About this Journal Submit a Manuscript Table of Contents 
Journal of Tropical Medicine
Volume 2012 (2012), Article ID 415057, 12 pages
doi:10.1155/2012/415057
Review Article

Genetic Diversity of Toll-Like Receptors and Immunity to M. leprae Infection

Bryan E. Hart1 and Richard I. Tapping1,2

1Department of Microbiology, University of Illinois, Urbana, IL 61801, USA
2College of Medicine, University of Illinois, Urbana, IL 61801, USA

Received 26 August 2011; Accepted 2 December 2011

Academic Editor: Carlos E. P. Corbett

Copyright © 2012 Bryan E. Hart and Richard I. Tapping. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Montoya and R. L. Modlin, “Learning from Leprosy. Insight into the human innate immune response,” Advances in Immunology, vol. 105, no. C, pp. 1–24, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. A. O. Aliprantis, R. B. Yang, M. R. Mark et al., “Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2,” Science, vol. 285, no. 5428, pp. 736–739, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Yoshimura, E. Lien, R. R. Ingalls, E. Tuomanen, R. Dziarski, and D. Golenbock, “Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2,” Journal of Immunology, vol. 163, no. 1, pp. 1–5, 1999. View at Scopus
  4. O. Takeuchi, S. Sato, T. Horiuchi et al., “Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins,” Journal of Immunology, vol. 169, no. 1, pp. 10–14, 2002. View at Scopus
  5. T. K. Means, E. Lien, A. Yoshimura, S. Wang, D. T. Golenbock, and M. J. Fenton, “The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for toll-like receptors,” Journal of Immunology, vol. 163, no. 12, pp. 6748–6755, 1999. View at Scopus
  6. T. K. Means, S. Wang, E. Lien, A. Yoshimura, D. T. Golenbock, and M. J. Fenton, “Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis,” Journal of Immunology, vol. 163, no. 7, pp. 3920–3927, 1999. View at Scopus
  7. R. Schwandner, R. Dziarski, H. Wesche, M. Rothe, and C. J. Kirschning, “Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2,” Journal of Biological Chemistry, vol. 274, no. 25, pp. 17406–17409, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. R. I. Tapping and P. S. Tobias, “Mycobacterial lipoarabinomannan mediates physical interactions between TLR1 and TLR2 to induce signaling,” Journal of Endotoxin Research, vol. 9, no. 4, pp. 264–268, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. J. Chan, X. Fan, S. W. Hunter, P. J. Brennan, and B. R. Bloom, “Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages,” Infection and Immunity, vol. 59, no. 5, pp. 1755–1761, 1991. View at Scopus
  10. G. Kaplan, R. R. Gandhi, and D. E. Weinstein, “Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro,” Journal of Immunology, vol. 138, no. 9, pp. 3028–3034, 1987.
  11. L. D. Sibley, S. W. Hunter, P. J. Brennan, and J. L. Krahenbuhl, “Mycobacterial lipoarabinomannan inhibits gamma interferon-mediated activation of macrophages,” Infection and Immunity, vol. 56, no. 5, pp. 1232–1236, 1988. View at Scopus
  12. S. R. Krutzik, M. T. Ochoa, P. A. Sieling et al., “Activation and regulation of Toll-like receptors 2 and 1 in human leprosy,” Nature Medicine, vol. 9, no. 5, pp. 525–532, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. H. Diaz-Silvestre, P. Espinosa-Cueto, A. Sanchez-Gonzalez et al., “The 19-kDa antigen of Mycobacterium tuberculosis is a major adhesin that binds the mannose receptor of THP-1 monocytic cells and promotes phagocytosis of mycobacteria,” Microbial Pathogenesis, vol. 39, no. 3, pp. 97–107, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. N. Banaiee, E. Z. Kincaid, U. Buchwald, W. R. Jacobs, and J. D. Ernst, “Potent inhibition of macrophage responses to IFN-γ by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2,” Journal of Immunology, vol. 176, no. 5, pp. 3019–3027, 2006. View at Scopus
  15. M. G. Drage, N. D. Pecora, A. G. Hise et al., “TLR2 and its co-receptors determine responses of macrophages and dendritic cells to lipoproteins of Mycobacterium tuberculosis,” Cellular Immunology, vol. 258, no. 1, pp. 29–37, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. S. M. Fortune, A. Solache, A. Jaeger et al., “Mycobacterium tuberculosis inhibits macrophage responses to IFN-γ through myeloid differentiation factor 88-dependent and -independent mechanisms,” Journal of Immunology, vol. 172, no. 10, pp. 6272–6280, 2004. View at Scopus
  17. A. J. Gehring, R. E. Rojas, D. H. Canaday, D. L. Lakey, C. V. Harding, and W. H. Boom, “The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and FcγR1 on human macrophages through toll-like receptor 2,” Infection and Immunity, vol. 71, no. 8, pp. 4487–4497, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. W. P. Lafuse, G. R. Alvarez, H. M. Curry, and B. S. Zwilling, “Mycobacterium tuberculosis and Mycobacterium avium inhibit IFN-γ-induced gene expression by TLR2-dependent and independent pathways,” Journal of Interferon and Cytokine Research, vol. 26, no. 8, pp. 548–561, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. R. N. Mahon, R. E. Rojas, S. A. Fulton, J. L. Franko, C. V. Harding, and W. H. Boom, “Mycobacterium tuberculosis cell wall glycolipids directly inhibit CD4 + T-cell activation by interfering with proximal T-cell-receptor signaling,” Infection and Immunity, vol. 77, no. 10, pp. 4574–4583, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. E. H. Noss, R. K. Pai, T. J. Sellati et al., “Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis,” Journal of Immunology, vol. 167, no. 2, pp. 910–918, 2001. View at Scopus
  21. R. K. Pai, M. Convery, T. A. Hamilton, W. Henry Boom, and C. V. Harding, “Inhibition of IFN-γ-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion,” Journal of Immunology, vol. 171, no. 1, pp. 175–184, 2003. View at Scopus
  22. M. E. Pennini, R. K. Pai, D. C. Schultz, W. H. Boom, and C. V. Harding, “Mycobacterium tuberculosis 19-kDa lipoprotein inhibits IFN-γ-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signaling,” Journal of Immunology, vol. 176, no. 7, pp. 4323–4330, 2006. View at Scopus
  23. R. K. Pai, M. E. Pennini, A. A. R. Tobian, D. H. Canaday, W. H. Boom, and C. V. Harding, “Prolonged toll-like receptor signaling by Mycobacterium tuberculosis and its 19-kilodalton lipoprotein inhibits gamma interferon-induced regulation of selected genes in macrophages,” Infection and Immunity, vol. 72, no. 11, pp. 6603–6614, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. M. Harboe, T. Oettinger, H. G. Wiker, I. Rosenkrands, and P. Andersen, “Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG,” Infection and Immunity, vol. 64, no. 1, pp. 16–22, 1996. View at Scopus
  25. A. L. Sorensen, S. Nagai, G. Houen, P. Andersen, and A. B. Andersen, “Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis,” Infection and Immunity, vol. 63, no. 5, pp. 1710–1717, 1995. View at Scopus
  26. S. K. Pathak, S. Basu, K. K. Basu et al., “Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages,” Nature Immunology, vol. 8, no. 6, pp. 610–618, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. A. Geluk, K. E. Van Meijgaarden, K. L. M. C. Franken et al., “Identification and characterization of the ESAT-6 homologue of Mycobacterium leprae and T-cell cross-reactivity with Mycobacterium tuberculosis,” Infection and Immunity, vol. 70, no. 5, pp. 2544–2548, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Bulut, K. S. Michelsen, L. Hayrapetian et al., “Mycobacterium tuberculosis heat shock proteins use diverse toll-like receptor pathways to activate pro-inflammatory signals,” Journal of Biological Chemistry, vol. 280, no. 22, pp. 20961–20967, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. A. Cehovin, A. R. M. Coates, Y. Hu et al., “Comparison of the moonlighting actions of the two highly homologous chaperonin 60 proteins of Mycobacterium tuberculosis,” Infection and Immunity, vol. 78, no. 7, pp. 3196–3206, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. D. Jung, S. K. Jeong, C. -M. Lee et al., “Enhanced efficacy of therapeutic cancer vaccines produced by Co-treatment with mycobacterium tuberculosis heparin-binding hemagglutinin, a novel TLR4 agonist,” Cancer Research, vol. 71, no. 8, pp. 2858–2870, 2011. View at Publisher · View at Google Scholar · View at PubMed
  31. P. Y. Bochud, D. Sinsimer, A. Aderem et al., “Polymorphisms in toll-like receptor 4 (TLR4) are associated with protection against leprosy,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 28, no. 9, pp. 1055–1065, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. T. H. Chuang and R. J. Ulevitch, “Cloning and characterization of a sub-family of human Toll-like receptors: hTLR7, hTLR8 and hTLR9,” European Cytokine Network, vol. 11, no. 3, pp. 372–378, 2000. View at Scopus
  33. C. A. Leifer, M. N. Kennedy, A. Mazzoni, C. Lee, M. J. Kruhlak, and D. M. Segal, “TLR9 is localized in the endoplasmic reticulum prior to stimulation,” Journal of Immunology, vol. 173, no. 2, pp. 1179–1183, 2004. View at Scopus
  34. P. Ahmad-Nejad, H. Häcker, M. Rutz, S. Bauer, R. M. Vabulas, and H. Wagner, “Bacterial CpG-DNA and lipopolysaccharides activate toll-like receptors at distinct cellular compartments,” European Journal of Immunology, vol. 32, no. 7, pp. 1958–1968, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. A. K. Kiemer, R. H. Senaratne, J. Hoppstädter et al., “Attenuated activation of macrophage TLR9 by DNA from virulent mycobacteria,” Journal of Innate Immunity, vol. 1, no. 1, pp. 29–45, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. A. Bafica, C. A. Scanga, C. G. Feng, C. Leifer, A. Cheever, and A. Sher, “TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis,” Journal of Experimental Medicine, vol. 202, no. 12, pp. 1715–1724, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. T. R. Hawn, E. A. Misch, S. J. Dunstan et al., “A common human TLR1 polymorphism regulates the innate immune response to lipopeptides,” European Journal of Immunology, vol. 37, no. 8, pp. 2280–2289, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. C. M. Johnson, E. A. Lyle, K. O. Omueti et al., “Cutting edge: a common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy,” Journal of Immunology, vol. 178, no. 12, pp. 7520–7524, 2007. View at Scopus
  39. E. A. Misch, M. Macdonald, C. Ranjit et al., “Human TLR1 deficiency is associated with impaired mycobacterial signaling and protection from leprosy reversal reaction,” PLoS Neglected Tropical Diseases, vol. 2, no. 5, article e231, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. X. Ma, Y. Liu, B. B. Gowen, E. A. Graviss, A. G. Clark, and J. M. Musser, “Full-exon resequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis disease,” PLoS ONE, vol. 2, no. 12, Article ID e1318, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. S. H. Wong, S. Gochhait, D. Malhotra et al., “Leprosy and the adaptation of human toll-like receptor 1,” PLoS Pathogens, vol. 6, no. 7, Article ID e1000979, pp. 1–9, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. R. P. Schilling, L. Hamann, W. R. Faber et al., “Polymorphism N248S in the human Toll-like receptor 1 gene is related to leprosy and leprosy reactions,” Journal of Infectious Diseases, vol. 199, no. 12, pp. 1816–1819, 2009. View at Publisher · View at Google Scholar · View at PubMed
  43. H.-D. Nischalke, M. Coenen, C. Berger et al., “The toll-like receptor 2 (TLR2)-196 to-174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C,” International Journal of Cancer, vol. 130, no. 6, pp. 1470–1475, 2011. View at Publisher · View at Google Scholar · View at PubMed
  44. E. Noguchi, F. Nishimura, H. Fukai et al., “An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population,” Clinical and Experimental Allergy, vol. 34, no. 2, pp. 177–183, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. D. R. Velez, C. Wejse, M. E. Stryjewski et al., “Variants in toll-like receptors 2 and 9 influence susceptibility to pulmonary tuberculosis in Caucasians, African-Americans, and West Africans,” Human Genetics, vol. 127, no. 1, pp. 65–73, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. P. Y. Bochud, T. R. Hawn, M. R. Siddiqui et al., “Toll-like receptor 2 (TLR2) polymorphisms are associated with reversal reaction in leprosy,” Journal of Infectious Diseases, vol. 197, no. 2, pp. 253–261, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. J.-J. Yim, L. Ding, A. A. Schäffer, G. Y. Park, Y.-S. Shim, and S. M. Holland, “A microsatellite polymorphism in intron 2 of human Toll-like receptor 2 gene: functional implications and racial differences,” FEMS Immunology and Medical Microbiology, vol. 40, no. 2, pp. 163–169, 2004. View at Publisher · View at Google Scholar · View at PubMed
  48. N. T. T. Thuong, T. R. Hawn, G. E. Thwaites et al., “A polymorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis,” Genes and Immunity, vol. 8, no. 5, pp. 422–428, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. E. Lorenz, J. P. Mira, K. L. Cornish, N. C. Arbour, and D. A. Schwartz, “A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection,” Infection and Immunity, vol. 68, no. 11, pp. 6398–6401, 2000. View at Publisher · View at Google Scholar · View at Scopus
  50. N. W.J. Schröder, I. Diterich, A. Zinke et al., “Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage lyme disease,” Journal of Immunology, vol. 175, no. 4, pp. 2534–2540, 2005.
  51. A. C. Ogus, B. Yoldas, T. Ozdemir et al., “The Arg753Gln polymorphism of the human Toll-like receptor 2 gene in tuberculosis disease,” European Respiratory Journal, vol. 23, no. 2, pp. 219–223, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. N. Dalgic, D. Tekin, Z. Kayaalti et al., “Arg753Gln polymorphism of the human Toll-like receptor 2 gene from infection to disease in pediatric tuberculosis,” Human Immunology, vol. 72, no. 5, pp. 440–445, 2011. View at Publisher · View at Google Scholar · View at PubMed
  53. D. M. Agnese, J. E. Calvano, S. J. Hahm et al., “Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections,” Journal of Infectious Diseases, vol. 186, no. 10, pp. 1522–1525, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. T. R. Hawn, A. Verbon, M. Janer, L. P. Zhao, B. Beutler, and A. Aderem, “Toll-like receptor 4 polymorphisms are associated with resistance to Legionnaires' disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 7, pp. 2487–2489, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. E. Lorenz, J. P. Mira, K. L. Frees, and D. A. Schwartz, “Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock,” Archives of Internal Medicine, vol. 162, no. 9, pp. 1028–1032, 2002. View at Scopus
  56. M. Fagerås Böttcher, M. Hmani-Aifa, A. Lindström et al., “A TLR4 polymorphism is associated with asthma and reduced lipopolysaccharide-induced interleukin-12(p70) responses in Swedish children,” Journal of Allergy and Clinical Immunology, vol. 114, no. 3, pp. 561–567, 2004. View at Publisher · View at Google Scholar · View at PubMed
  57. C. Schmitt, A. Humeny, C. M. Becker, K. Brune, and A. Pahl, “Polymorphisms of TLR4: rapid genotyping and reduced response to lipopolysaccharide of TLR4 mutant alleles,” Clinical Chemistry, vol. 48, no. 10, pp. 1661–1667, 2002. View at Scopus
  58. D. A. Schwartz, “The role of TLR4 in endotoxin responsiveness in humans,” Journal of Endotoxin Research, vol. 7, no. 5, pp. 389–393, 2001. View at Publisher · View at Google Scholar · View at Scopus
  59. R. N. Douville, Y. Lissitsyn, A. F. Hirschfeld et al., “TLR4 Asp299Gly and Thr399ile polymorphisms: no impact on human immune responsiveness to LPS or respiratory syncytial virus,” PLoS ONE, vol. 5, no. 8, Article ID e12087, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  60. C. Erridge, J. Stewart, and I. R. Poxton, “Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling,” Journal of Experimental Medicine, vol. 197, no. 12, pp. 1787–1791, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  61. C. Van Der Graaf, B. J. Kullberg, L. Joosten et al., “Functional consequences of the Asp299Gly Toll-like receptor-4 polymorphism,” Cytokine, vol. 30, no. 5, pp. 264–268, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. N. Najmi, G. Kaur, S. K. Sharma, and N. K. Mehra, “Human Toll-like receptor 4 polymorphisms TLR4 Asp299Gly and Thr399Ile influence susceptibility and severity of pulmonary tuberculosis in the Asian Indian population,” Tissue Antigens, vol. 76, no. 2, pp. 102–109, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. B. Ferwerda, G. S. Kibiki, M. G. Netea, W. M. V. Dolmans, and A. J. Van Der Ven, “The toll-like receptor 4 Asp299Gly variant and tuberculosis susceptibility in HIV-infected patients in Tanzania,” AIDS, vol. 21, no. 10, pp. 1375–1377, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. J. Fitness, S. Floyd, D. K. Warndorff et al., “Large-scale candidate gene study of leprosy susceptibility in the Karonga district of northern Malawi,” American Journal of Tropical Medicine and Hygiene, vol. 71, no. 3, pp. 330–340, 2004. View at Scopus
  65. A. M. Cooper, D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme, “Disseminated tuberculosis in interferon γ gene-disrupted mice,” Journal of Experimental Medicine, vol. 178, no. 6, pp. 2243–2247, 1993. View at Publisher · View at Google Scholar · View at Scopus
  66. J. A. Cunningham, J. D. Kellner, P. J. Bridge, C. L. Trevenen, D. R. McLeod, and H. D. Davies, “Disseminated bacille Calmette-Guerin infection in an infant with a novel deletion in the interferon-gamma receptor gene,” International Journal of Tuberculosis and Lung Disease, vol. 4, no. 8, pp. 791–794, 2000. View at Scopus
  67. P. Kumar, R. Agarwal, I. Siddiqui, H. Vora, G. Das, and P. Sharma, “ESAT6 differentially inhibits IFN-γ-inducible class II transactivator isoforms in both a TLR2-dependent and -independent manner,” Immunology and Cell Biology. In press. View at Publisher · View at Google Scholar · View at PubMed
  68. M. E. Pennini, Y. Liu, J. Yang, C. M. Croniger, W. Henry Boom, and C. V. Harding, “CCAAT/enhancer-binding protein β and δ binding to CIITA promoters is associated with the inhibition of CIITA expression in response to Mycobacterium tuberculosis 19-kDa lipoprotein,” Journal of Immunology, vol. 179, no. 10, pp. 6910–6918, 2007. View at Scopus
  69. I. Pulido, M. Leal, M. Genebat, Y. M. Pacheco, M. E. Sáez, and N. Soriano-Sarabia, “The TLR4 ASP299GLY polymorphism is a risk factor for active tuberculosis in caucasian HIV-infected patients,” Current HIV Research, vol. 8, no. 3, pp. 253–258, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. P. Das, A. Lahiri, A. Lahiri, and D. Chakravortty, “Modulation of the arginase pathway in the context of microbial pathogenesis: a metabolic enzyme moonlighting as an immune modulator,” PLoS Pathogens, vol. 6, no. 6, article e1000899, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  71. M. T. Talaue, V. Venketaraman, M. H. Hazbón et al., “Arginine homeostasis in J774.1 macrophages in the context of Mycobacterium bovis BCG infection,” Journal of Bacteriology, vol. 188, no. 13, pp. 4830–4840, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  72. K. C. El Kasmi, J. E. Qualls, J. T. Pesce et al., “Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens,” Nature Immunology, vol. 9, no. 12, pp. 1399–1406, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  73. J. E. Qualls, G. Neale, A. M. Smith et al., “Arginine usage in mycobacteria-infected macrophages depends on autocrine-paracrine cytokine signaling,” Science Signaling, vol. 3, no. 135, p. ra62, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  74. E. Spierings, T. De Boer, B. Wieles, L. B. Adams, E. Marani, and T. H. M. Ottenhoff, “Mycobacterium leprae-specific, HLA class II-restricted killing of human Schwann cells by CD4+ Th1 cells: a novel immunopathogenic mechanism of nerve damage in leprosy,” Journal of Immunology, vol. 166, no. 10, pp. 5883–5888, 2001. View at Scopus
  75. R. B. Oliveira, M. T. Ochoa, P. A. Sieling et al., “Expression of toll-like receptor 2 on human schwann cells: a mechanism of nerve damage in leprosy,” Infection and Immunity, vol. 71, no. 3, pp. 1427–1433, 2003. View at Publisher · View at Google Scholar · View at Scopus
  76. S. Goethals, E. Ydens, V. Timmerman, and S. Janssens, “Toll-like receptor expression in the peripheral nerve,” GLIA, vol. 58, no. 14, pp. 1701–1709, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  77. M. López, L. M. Sly, Y. Luu, D. Young, H. Cooper, and N. E. Reiner, “The 19-kDa Mycobacterium tuberculosis protein induces macrophage apoptosis through toll-like receptor-2,” Journal of Immunology, vol. 170, no. 5, pp. 2409–2416, 2003. View at Scopus
  78. G. Robbins, V. Mushrif Tripathy, V. N. Misra et al., “Ancient skeletal evidence for leprosy in India (2000 B.C.),” PLoS ONE, vol. 4, no. 5, Article ID e5669, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  79. I. Hershkovitz, H. D. Donoghue, D. E. Minnikin et al., “Detection and molecular characterization of 9000-year-old Mycobacterium tuberculosis from a neolithic settlement in the Eastern mediterranean,” PLoS ONE, vol. 3, no. 10, Article ID e3426, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  80. L. B. Barreiro, M. Ben-Ali, H. Quach et al., “Evolutionary dynamics of human toll-like receptors and their different contributions to host defense,” PLoS Genetics, vol. 5, no. 7, Article ID e1000562, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  81. D. Enard, F. Depaulis, and H. R. Crollius, “Human and non-human primate genomes share hotspots of positive selection,” PLoS Genetics, vol. 6, no. 2, Article ID e1000840, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus